These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28912145)

  • 21. Diagnostic performance of
    Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Oosone K; Kuwano H
    Anticancer Res; 2016 Jan; 36(1):393-7. PubMed ID: 26722071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
    Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
    Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of 2-[18F]-2-deoxy-D-glucose positron emission tomography in staging of regional lymph nodes in patients with cutaneous malignant melanoma.
    Macfarlane DJ; Sondak V; Johnson T; Wahl RL
    J Clin Oncol; 1998 May; 16(5):1770-6. PubMed ID: 9586890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of FDG PET/CT and contrast-enhanced MSCT in detecting lymph node metastasis of esophageal cancer.
    Tan R; Yao SZ; Huang ZQ; Li J; Li X; Tan HH; Liu QW
    Asian Pac J Cancer Prev; 2014; 15(18):7719-24. PubMed ID: 25292052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (18)F-FDG and (18)F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Rayamajhi SJ; Mittal BR; Maturu VN; Agarwal R; Bal A; Dey P; Shukla J; Gupta D
    Ann Nucl Med; 2016 Apr; 30(3):207-16. PubMed ID: 26661845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic lymph node dissection in metastatic melanoma to the groin should not be abandoned yet.
    Faut M; Kruijff S; Hoekstra HJ; van Ginkel RJ; Been LB; van Leeuwen BL
    Eur J Surg Oncol; 2018 Nov; 44(11):1779-1785. PubMed ID: 30054111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nondetection of sentinel lymph node with lymphoscintigraphy as a result of massive malignant invasion shown by positron emission tomography.
    Blocklet D; Donckier V; Vereecken P; Van Geertruyden J; Laporte M; Goldman S
    Clin Nucl Med; 2001 Dec; 26(12):1013-5. PubMed ID: 11711703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Dual-Timepoint
    Collarino A; Garganese G; Valdés Olmos RA; Stefanelli A; Perotti G; Mirk P; Fragomeni SM; Ieria FP; Scambia G; Giordano A; Rufini V
    J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging of regional nodes in AJCC stage I and II melanoma: 18FDG PET imaging versus sentinel node detection.
    Belhocine T; Pierard G; De Labrassinne M; Lahaye T; Rigo P
    Oncologist; 2002; 7(4):271-8. PubMed ID: 12185291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
    Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
    Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume.
    Wagner JD; Schauwecker DS; Davidson D; Wenck S; Jung SH; Hutchins G
    J Surg Oncol; 2001 Aug; 77(4):237-42. PubMed ID: 11473371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the
    Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N
    Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential
    Pietrzak A; Kazmierska J; Cholewinski W
    Hell J Nucl Med; 2017; 20 Suppl():80-92. PubMed ID: 29324917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT.
    Yun M; Lim JS; Noh SH; Hyung WJ; Cheong JH; Bong JK; Cho A; Lee JD
    J Nucl Med; 2005 Oct; 46(10):1582-8. PubMed ID: 16204706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
    Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
    J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoscintigraphy in breast cancer patients after neoadjuvant chemotherapy. Diagnostic value and the work-up of sentinel node negative patients.
    Dalus K; Reitsamer R; Holzmannhofer J; Rendl G; Pirich C; Kronberger C; Rettenbacher L
    Nuklearmedizin; 2011; 50(1):33-8. PubMed ID: 21336417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.